❌

Reading view

South Australia Launches AI Royal Commission: What Businesses Should Expect

South Australia is launching an AI royal commission to examine how the technology is reshaping work, public services, and the economy. Businesses should expect greater scrutiny of AI governance, privacy, workforce use, and accountability as separate federal standards and privacy rules move forward.
  •  

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

Independent advisors for the Food and Drug Administration on Friday voted 9–0 in support of approving Moderna's seasonal mRNA flu vaccine, which a Trump appointee at the agency initially tried to block from even being reviewed.

In an all-day meeting, members of the FDA's advisory committeeβ€”known as VRBPAC for Vaccines and Related Biological Products Advisory Committeeβ€”pored over data and presentations on the vaccine, which is dubbed mRNA-1010 and branded as mFlusiva. The presentations included a review from FDA scientists, which was supportive of the vaccine.

Data from a Phase 3 trial including over 40,000 adults age 50 and older found the mRNA vaccine was around 27 percent more effective against seasonal flu than a standard flu shot. A smaller Phase 3 trial, involving data from nearly 3,000 people age 65 years and older, showed the shot produces stronger immune responses than a high-dose flu vaccine, which is recommended for this age group. The safety profile of the vaccine was also generally good.

Read full article

Comments

Β© DeFodi Images

  •  
❌